ANIP - ANI PHARMACEUTICALS INC
IEX Last Trade
54.71
-0.810 -1.481%
Share volume: 0
Last Updated: Fri 27 Dec 2024 03:29:45 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.05%
PREVIOUS CLOSE
CHG
CHG%
$55.52
-0.81
-1.46%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-10 | 2022-08-08 | 2022-11-09 | 2023-03-09 | 2023-05-08 | 2023-08-09 | 2023-11-08 | 2024-02-29 | |
| Total revenue | 64.477 M | 73.855 M | 83.821 M | 94.232 M | 106.786 M | 116.547 M | 131.829 M | 131.654 M | |
| Cost of revenue | 34.271 M | 35.294 M | 32.894 M | 36.326 M | 37.708 M | 42.284 M | 48.101 M | 53.420 M | |
| Gross profit | 30.206 M | 38.561 M | 50.927 M | 57.906 M | 69.078 M | 74.263 M | 83.728 M | 78.234 M | |
| 27.66% | 32.07% | 13.70% | 19.29% | 7.51% | 12.75% | -6.56% | |||
| Operating expenses | 34.091 M | 36.123 M | 37.738 M | 38.410 M | 42.392 M | 46.134 M | 53.128 M | 54.329 M | |
| Selling general and admin | 28.817 M | 31.958 M | 30.081 M | 33.188 M | 36.468 M | 38.760 M | 42.007 M | 44.462 M | |
| Research and development | 5.274 M | 4.165 M | 7.657 M | 5.222 M | 5.924 M | 7.374 M | 11.121 M | 9.867 M | |
| Total expenses | 82.919 M | 85.181 M | 84.799 M | 89.220 M | 94.800 M | 103.108 M | 116.436 M | 122.943 M | |
| 2.73% | -0.45% | 5.21% | 6.25% | 8.76% | 12.93% | 5.59% | |||
| Operating income | -18.442 M | -11.326 M | -978.000 K | 5.012 M | 11.986 M | 13.439 M | 15.393 M | 8.711 M | |
| Ebit | -18.442 M | -11.326 M | -978.000 K | 5.012 M | 11.986 M | 13.439 M | 15.393 M | 8.711 M | |
| Pretax income | -25.897 M | -18.818 M | -12.222 M | -5.728 M | 2.165 M | 5.249 M | 11.511 M | 947.000 K | |
| -27.34% | -35.05% | -53.13% | -137.80% | 142.45% | 119.30% | -91.77% | |||
| Income tax | -5.767 M | -3.895 M | -3.622 M | -1.485 M | 726.000 K | -996.000 K | 1.571 M | -208.000 K | |
| Net income basic | -20.130 M | -15.330 M | -9.006 M | -4.650 M | 920.000 K | 5.249 M | 9.534 M | 1.451 M | |
| 23.85% | 41.25% | 48.37% | 119.78% | 470.54% | 81.63% | -84.78% | |||
| Net income | -20.130 M | -15.330 M | -9.006 M | -4.650 M | 920.000 K | 5.249 M | 9.534 M | 1.451 M | |
| 23.85% | 41.25% | 48.37% | 119.78% | 470.54% | 81.63% | -84.78% |